News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
814,364 Results
Type
Article (75443)
Company Profile (643)
Press Release (738278)
Section
Business (227998)
Career Advice (3772)
Deals (39219)
Drug Delivery (127)
Drug Development (89247)
Employer Resources (195)
FDA (17815)
Job Trends (17095)
News (388126)
Policy (38761)
Tag
Academia (2980)
Alliances (56073)
Alzheimer's disease (1430)
Approvals (17768)
Artificial intelligence (247)
Bankruptcy (397)
Best Places to Work (12632)
Biotechnology (440)
Breast cancer (249)
Cancer (1899)
Cardiovascular disease (154)
Career advice (3207)
CAR-T (146)
Cell therapy (420)
Clinical research (71474)
Collaboration (749)
Compensation (389)
COVID-19 (2843)
C-suite (186)
Data (1720)
Diabetes (241)
Diagnostics (6841)
Earnings (93198)
Employer resources (166)
Events (127605)
Executive appointments (622)
FDA (18808)
Funding (663)
Gene therapy (295)
GLP-1 (784)
Government (5065)
Healthcare (20838)
Infectious disease (2972)
Inflammatory bowel disease (139)
Interviews (740)
IPO (17674)
Job creations (4975)
Job search strategy (2626)
Layoffs (523)
Legal (9905)
Lung cancer (279)
Manufacturing (274)
Medical device (14510)
Medtech (14515)
Mergers & acquisitions (21923)
Metabolic disorders (651)
Neuroscience (1904)
NextGen: Class of 2025 (7632)
Non-profit (5077)
Northern California (2223)
Obesity (360)
Opinion (264)
Patents (186)
People (63738)
Phase I (22062)
Phase II (31168)
Phase III (23500)
Pipeline (804)
Postmarket research (3280)
Preclinical (9720)
Radiopharmaceuticals (264)
Rare diseases (370)
Real estate (7157)
Regulatory (25748)
Research institute (2649)
Resumes & cover letters (589)
Southern California (1924)
Startups (4188)
United States (20426)
Vaccines (728)
Weight loss (273)
Date
Last 7 days (873)
Last 30 days (2807)
Last 365 days (36895)
2025 (5689)
2024 (37915)
2023 (42567)
2022 (53927)
2021 (58722)
2020 (57665)
2019 (51316)
2018 (39098)
2017 (36857)
2016 (37803)
2015 (43829)
2014 (38601)
2013 (34721)
2012 (36582)
2011 (36633)
2010 (36207)
Location
Africa (1197)
Arizona (227)
Asia (48452)
Australia (8340)
California (5200)
Canada (1783)
China (436)
Colorado (239)
Connecticut (258)
Europe (109652)
Florida (752)
Georgia (183)
Illinois (535)
Indiana (290)
Maryland (825)
Massachusetts (4074)
Michigan (224)
Minnesota (369)
New Jersey (1472)
New York (1477)
North Carolina (998)
Northern California (2223)
Ohio (187)
Pennsylvania (1164)
South America (1570)
Southern California (1924)
Texas (765)
Utah (161)
Washington State (517)
814,364 Results for "mitsui and co ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Lokavant Announces $8M Strategic Investment from Mitsui & Co. to Expand AI and Predictive Clinical Trial Intelligence into Asia-Pacific
Lokavant , the clinical trial intelligence platform company, today announces an $8 million strategic investment from global business titan Mitsui & Co. Ltd. to expand its AI-optimized platform across the Asia-Pacific (APAC) region.
October 3, 2023
·
3 min read
Business
Takeda, Astellas and Sumitomo Mitsui Banking Announce Master Agreement to Establish Joint Venture Company for Incubation of Early Drug Discovery Programs
Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., and Sumitomo Mitsui Banking Corporation announced that the three companies signed a master agreement on April 22, 2024, to establish a joint venture company.
April 22, 2024
·
5 min read
Job Trends
Astellas Establishes Open Innovation Hub for Tumor Microenvironment Research with Cutting-Edge Spatial Biology, in Mitsui Fudosan’s “MITSUI LINK-Lab KASHIWA-NO-HA 1"
Astellas Pharma Inc. and Mitsui Fudosan Co., Ltd. announced that Astellas will establish a “TME imaging and interactive research for innovation " open innovation hub in October, 2023 in “MITSUI LINK-Lab KASHIWA-NO-HA 1" operated by Mitsui Fudosan.
June 29, 2023
·
6 min read
Press Releases
Meiji Seika Pharma: Announcement of the Establishment of Local Subsidiary “Taiwan Meiji Pharma Co., Ltd.” in Taiwan
December 25, 2024
·
1 min read
Press Releases
Park Ha Biological Technology Co., Ltd. Announces Closing of $4.8 Million Initial Public Offering
December 31, 2024
·
4 min read
Press Releases
Rege Nephro Co., Ltd. Successfully Completes Series B Funding to Accelerate Kidney Disease Therapy Trials
October 8, 2024
·
3 min read
Press Releases
Park Ha Biological Technology Co., Ltd. Announces Pricing of $4.8 Million Initial Public Offering
December 26, 2024
·
4 min read
Meihua International Medical Technologies Co., Ltd. Announces Share Repurchase Program of Up to $3 million
Meihua International Medical Technologies Co., Ltd., a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries in China, announced that its board of directors has approved and authorized a share repurchase program of up to $3 million of the Company’s outstanding ordinary shares.
July 1, 2024
·
5 min read
Drug Development
Rege Nephro CO., Ltd. Announces Patient Enrollment for Phase II Clinical Trial of Tamibarotene for ADPKD
Rege Nephro CO., Ltd. (https://www.regenephro.co.jp/en) has announced that patient enrollment began in April for the second stage of its Phase II clinical trial of tamibarotene as a developmental product for the treatment of autosomal dominant polycystic kidney disease (ADPKD) under the code RN-014.
May 28, 2024
·
2 min read
Press Releases
Newron and EA Pharma (A Subsidiary of Eisai Co., Ltd.) Announce License Agreement for Evenamide in Japan and Other Asian Territories
December 13, 2024
·
11 min read
1 of 81,437
Next
